Marc Ballas

Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas

Matthias A. Karajannis, Geneviève Legault, Mari Hagiwara et al. · Neuro-Oncology · 2012 · 184 citations · Full text

Medicine, Oncology, Otolaryngology +17

A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study

David Planchard, Takashi Yokoi, Michael McCleod et al. · Clinical Lung Cancer · 2016 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC

Todd M. Bauer, Benjamin Besse, Alex Martínez‐Martí et al. · Journal of Thoracic Oncology · 2019 · 78 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in <i>PTEN</i>

Takefumi Komiya, Gideon M. Blumenthal, Roopa DeChowdhury et al. · The Oncologist · 2019 · 66 citations · Full text

Medicine, Oncology, Pathology +17

A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer

D. Ross Camidge, Eamon M. Berge, Robert C. Doebele et al. · Journal of Thoracic Oncology · 2014 · 51 citations · Full text

Medicine, Oncology, Pharmacotherapy +16